Decreased Natural Killer Cells in Mucormycosis
Authors:
- Alejandra Albarrán-SánchezAAAlejandra Albarrán-Sánchez
- Luis M. Borges-LópezLBLuis M. Borges-López
- Lourdes A. Arriaga-PizanoLALourdes A. Arriaga-Pizano
- Patricia O’FArril-RomanilosPOPatricia O’FArril-Romanilos
- Elsy Estefania Pérez-PedrazaEPElsy Estefania Pérez-Pedraza
- Aldo Ferreira-HermosilloAldo Ferreira-Hermosillo
- Jesus Emmanuel Juárez-PalaciosJJJesus Emmanuel Juárez-Palacios
- 4 June 2026
- journal article
- Published by Elsevier in Archives of Medical Research
- Vol. 57 (7) , 103453
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- MucormycosisNew England Journal of Medicine, 2026
- Dysregulation of NK cell subsets and phenotypes in COVID-19 patients with comorbid type 2 diabetesClinical Science, 2025
- COVID-19–associated mucormycosis: a systematic review and meta-analysis of 958 casesClinical Microbiology and Infection, 2023
- Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemicFolia Microbiologica, 2022
- Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of LiteratureMycopathologia, 2021
- Epidemiology and clinical outcomes of invasive mould infections in Indian intensive care units (FISF study)Journal of Critical Care, 2019
- The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reportsClinical Microbiology and Infection, 2019
- Recent Advances in the Pathogenesis of MucormycosesClinical Therapeutics, 2018
- The mucormycete–host interfaceCurrent Opinion in Microbiology, 2017
- Rhizopus oryzae hyphae are damaged by human natural killer (NK) cells, but suppress NK cell mediated immunityImmunobiology, 2013